Downregulation of miR-199a-3p in Hepatocellular Carcinoma and Its Relevant Molecular Mechanism via GEO, TCGA Database and In Silico Analyses

被引:5
|
作者
Liu, An-gui [1 ]
Pang, Yu-yan [2 ]
Chen, Gang [2 ]
Wu, Hua-Yu [3 ,4 ]
He, Rong-Quan [1 ]
Dang, Yi-wu [2 ]
Huang, Zhi-guang [2 ]
Zhang, Rui [2 ]
Ma, Jie [1 ,2 ]
Yang, Li-hua [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Oncol, Nanning 530021, Guangxi Zhuang, Peoples R China
[2] Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, Nanning 530021, Guangxi Zhuang, Peoples R China
[3] Guangxi Med Univ, Affiliated Hosp 1, Dept Cell Biol, Nanning 530021, Guangxi Zhuang, Peoples R China
[4] Guangxi Med Univ, Affiliated Hosp 1, Dept Genet, Nanning 530021, Guangxi Zhuang, Peoples R China
关键词
hepatocellular carcinoma; miR-199a-3p; Gene Expression Omnibus; qRT-PCR; CELL-PROLIFERATION; THERAPEUTIC TARGETS; TUMOR-GROWTH; LUNG-CANCER; MICRORNA-199A-3P; EXPRESSION; MICRORNAS; IDENTIFICATION; INVASION; METASTASIS;
D O I
10.1177/1533033820979670
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Existing reports have demonstrated that miR-199a-3p plays a role as a tumor suppressor in a variety of human cancers. This study aims to further validate the expression of miR-199a-3p in HCC and to explore its underlying mechanisms by using multiple data sets. Chip data or sequencing data and quantitative reverse transcription polymerase chain reaction (qRT-PCR) were integrated to assess the expression of miR-199a-3p in HCC. The potential targets and transcription factor regulatory network of miR-199a-3p in HCC were determined and possible biological mechanism of miR-199a-3p was analyzed with bioinformatics methods. In the results, miR-199a-3p expression was significantly lower in HCC tissues compared to normal tissues according to chip data or sequencing data and qRT-PCR. Moreover, 455 targets of miR-199a-3p were confirmed, and these genes were involved in the PI3K-Akt signaling pathway, pathways in cancer, and focal adhesions. LAMA4 was considered a key target of miR-199a-3p. In CMTCN, 11 co-regulatory pairs, 3 TF-FFLs, and 2 composite-FFLs were constructed. In conclusion, miR-199a-3p was down regulated in HCC and LAMA4 may be a potential target of miR-199a-3p in HCC.
引用
收藏
页数:17
相关论文
共 39 条
  • [31] Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism
    Chunyu Cao
    Changjiang Wang
    Clinical and Experimental Medicine, 2020, 20 : 569 - 576
  • [32] RETRACTED: Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma (Publication with Expression of Concern. See vol. 42, 2022) (Retracted Article)
    Zhang, Kun
    Shao, Chu-xiao
    Zhu, Jin-de
    Lv, Xin-liang
    Tu, Chao-yong
    Jiang, Chuan
    Shang, Min-jie
    BIOSCIENCE REPORTS, 2020, 40
  • [33] A qRT-PCR and Gene Functional Enrichment Study Focused on Downregulation of miR-141-3p in Hepatocellular Carcinoma and Its Clinicopathological Significance
    Liu, Cui-zhen
    Ye, Zhi-hua
    Ma, Jie
    He, Rong-quan
    Liang, Hai-wei
    Peng, Zhi-gang
    Chen, Gang
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2017, 16 (06) : 835 - 849
  • [34] Potential targets and molecular mechanism of miR-331-3p in hepatocellular carcinoma identified by weighted gene coexpression network analysis
    Chi, Qingjia
    Geng, Xinge
    Xu, Kang
    Wang, Chunli
    Zhao, Han
    BIOSCIENCE REPORTS, 2020, 40
  • [35] Down-regulation of miR-133a-3p in hepatocellular carcinoma tissues and its potential regulatory molecular mechanism: a study of qRT-PCR and bioinformatics analysis
    Wen, Dong-Yue
    Xie, Zu-Cheng
    Luo, Jie
    Gao, Li
    Zhang, Xiang-Yu
    Liang, Hai-Wei
    Ackbarkhan, Zacharia
    Wang, Han-Lin
    Yang, Xia
    Ye, Zhi-Hua
    Huang, Xue-Yi
    He, Yun
    Yang, Hong
    Li, Zu-Yun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (01): : 23 - 38
  • [36] Novel Insights into MEG3/miR664a-3p/ADH4 Axis and Its Possible Role in Hepatocellular Carcinoma from an in Silico Perspective
    Karunakara, Shreyas H.
    Puttahanumantharayappa, Lakshana D.
    Gowda, Nirmala Sannappa G.
    Shiragannavar, Varsha D.
    Santhekadur, Prasanna K.
    GENES, 2022, 13 (12)
  • [37] Unraveling the oncogenic role of LINC00504 and its interaction with miR-545-3p and ARIHI in hepatocellular carcinoma: novel insights for molecular therapy
    E. Ke
    Kai Yang
    Qin Zhang
    Cheng Luo
    Zhiyong Hu
    Jing Wang
    Hai Zhang
    Discover Oncology, 16 (1)
  • [38] Upregulated miR-203a-3p and its potential molecular mechanism in breast cancer: A study based on bioinformatics analyses and a comprehensive meta-analysis
    Cai, Kai-Teng
    Feng, Cai-Xia
    Zhao, Jin-Che
    He, Rong-Quan
    Ma, Jie
    Zhong, Jin-Cai
    MOLECULAR MEDICINE REPORTS, 2018, 18 (06) : 4994 - 5008
  • [39] The clinical value of miR-193a-3p in non-small cell lung cancer and its potential molecular mechanism explored in silico using RNA-sequencing and microarray data
    Gao, Xiang
    Tang, Rui-xue
    Xie, Qiong-ni
    Lin, Jia-ying
    Shi, Hong-lan
    Chen, Gang
    Li, Zu-yun
    FEBS OPEN BIO, 2018, 8 (01): : 94 - 109